{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:44:14Z","timestamp":1789919054796,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CNPq-Procad\/Casadinho","award":["479526\/2012-5"],"award-info":[{"award-number":["479526\/2012-5"]}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.euroneuro.2016.08.007","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T05:06:35Z","timestamp":1474434395000},"page":"1590-1600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors"],"prefix":"10.1016","volume":"26","author":[{"given":"Helen","family":"de Morais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila P.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa M.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele M.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane Hatsuko","family":"Baggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Vanvossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milene","family":"Cristina de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Eduardo","family":"da Silva-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Jos\u00e9","family":"Bertoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joice M.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaina M.","family":"Zanoveli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2016.08.007_bib1","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","article-title":"The prevalence of comorbid depression in adults with diabetes: a meta-analysis","volume":"24","author":"Anderson","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0447.2011.01687.x","article-title":"Endocannabinoid system dysfunction in mood and related disorders","volume":"124","author":"Ashton","year":"2011","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib3","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1523\/JNEUROSCI.1636-07.2007","article-title":"Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex","volume":"27","author":"Bambico","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.expneurol.2009.12.022","article-title":"Hippocampal neurovascular and hypothalamic-pituitary-adrenal axis alterations in spontaneously type 2 diabetic GK rats","volume":"222","author":"Beauquis","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0031-9384(91)90424-M","article-title":"The functional significance of biochemical alterations in streptozotocin-induced diabetes","volume":"50","author":"Bellush","year":"1991","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.freeradbiomed.2011.01.007","article-title":"Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress","volume":"51","author":"Booz","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib7","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-511X-13-43","article-title":"The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes","volume":"13","author":"Cable","year":"2014","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/0269881110389209","article-title":"Central, but not basolateral, amygdala involvement in the anxiolytic-like effects of midazolam in rats in the elevated plus maze","volume":"26","author":"Carvalho","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2016.08.007_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/biof.1168","article-title":"Endocannabinoids and energy homeostasis: an update","volume":"40","author":"Cristino","year":"2014","journal-title":"Biofactors"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-015-9617-0","article-title":"Indoleamine-2,3-dioxygenase\/kynurenine pathway as a potential pharmacological target to treat depression associated with diabetes","author":"da Silva Dias","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbd.2007.04.017","article-title":"The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells","volume":"27","author":"Dagon","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1573399811666150223123053","article-title":"Major depressive disorder and diabetes: does serotonin bridge the gap?","volume":"11","author":"De Long","year":"2015","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbr.2013.10.011","article-title":"Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats","volume":"258","author":"de Morais","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib18","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-3-642-17214-4_4","article-title":"Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes","volume":"203","author":"Di Marzo","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.expneurol.2006.11.013","article-title":"Increase of cannabinoid CB1 receptor density in the hippocampus of streptozotocin-induced diabetic rats","volume":"204","author":"Duarte","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib21","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.prostaglandins.2013.02.002","article-title":"Endogenous cannabinoids revisited: a biochemistry perspective","volume":"102","author":"Fonseca","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0302-4598(98)00072-5","article-title":"Mechanism of pyrogallol autoxidation and deter-mination of superoxide dimutase enzyme activity","volume":"45","author":"Gao","year":"1998","journal-title":"Bioelectrochem. Bioenerg."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/978-3-319-20825-1_13","article-title":"Endocannabinoids and metabolic disorders","volume":"231","author":"Gatta-Cherifi","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib25","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuint.2010.07.001","article-title":"Physical exercise in adolescence changes CB1 cannabinoid receptor expression in the rat brain","volume":"57","author":"Gomes da Silva","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0091-3057(00)00221-5","article-title":"Ethopharmacology of the antidepressant effect of clonazepam in diabetic rats","volume":"66","author":"Gomez","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2014.09.041","article-title":"Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system","volume":"744","author":"Gupta","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib30","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1471-4159.2008.05567.x","article-title":"Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment","volume":"106","author":"Hill","year":"2008","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.euroneuro.2016.08.007_bib31","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1471-4159.2008.05567.x","article-title":"Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment","volume":"106","author":"Hill","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejphar.2004.06.069","article-title":"Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress","volume":"499","author":"Hill","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.euroneuro.2005.03.003","article-title":"Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test","volume":"15","author":"Hill","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.physbeh.2011.09.003","article-title":"Depressive phenotypes evoked by experimental diabetes are reversed by insulin","volume":"105","author":"Ho","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1100\/tsw.2002.139","article-title":"Cannabinoids on the brain","volume":"2","author":"Irving","year":"2002","journal-title":"Sci. World J."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0003-2697(92)90122-N","article-title":"Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein","volume":"202","author":"Jiang","year":"1992","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.euroneuro.2016.08.007_bib38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.autrev.2016.02.008","article-title":"Cannabinoids and autoimmune diseases: a systematic review","volume":"15","author":"Katchan","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.euroneuro.2016.08.007_bib39","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/db10-1550","article-title":"Cannabinoids inhibit insulin receptor signaling in pancreatic \u03b2-cells","volume":"60","author":"Kim","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2015.01.051","article-title":"Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system","volume":"284","author":"Kruk-Slomka","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"8","key":"10.1016\/j.euroneuro.2016.08.007_bib41","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2005-2679","article-title":"Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia","volume":"91","author":"Matias","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib42","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.neuropharm.2003.11.004","article-title":"Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain","volume":"46","author":"Mato","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuroscience.2011.07.052","article-title":"Cannabinoids and emotionality: a neuroanatomical perspective","volume":"204","author":"McLaughlin","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/FBP.0b013e3282ee7b44","article-title":"Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect","volume":"18","author":"Mclaughlin","year":"2007","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2016.08.007_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2012.12.002","article-title":"Endocannabinoid system and mood disorders: priming a target for new therapies","volume":"138","author":"Micale","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib46","series-title":"Cannabinoid Modulation of Emotion, Memory, and Motivation","article-title":"Role of the endocannabinoid system in depression: from preclinical to clinical evidence","author":"Micale","year":"2015"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib47","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/hipo.10025","article-title":"Coexistence of serotonin 3 (5-HT3) and CB1 cannabinoid receptors in interneurons of hippocampus and dentate gyrus","volume":"12","author":"Morales","year":"2002","journal-title":"Hippocampus"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S2213-8587(15)00134-5","article-title":"The link between depression and diabetes: the search for shared mechanisms","volume":"3","author":"Moulton","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib49","first-page":"696215","article-title":"Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress","author":"Naudi","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib50","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.bp.114.154781","article-title":"Depressive symptoms and all-cause mortality in people with type 2 diabetes: a focus on potential mechanisms","author":"Nefs","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.diabres.2013.05.009","article-title":"Treatment of depression in type 2 diabetic patients: effects on depressive symptoms, quality of life and metabolic control","volume":"101","author":"Nicolau","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2006.09.110","article-title":"Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex","volume":"1127","author":"Oropeza","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"\"Behavioural despair\" in rats and mice: strain differences and the effects of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0253-7613.150305","article-title":"Diabetes-associated depression: the serotonergic system as a novel multifunctional target","volume":"47","author":"Prabhakar","year":"2015","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.expneurol.2012.05.016","article-title":"Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure","volume":"236","author":"Reyes","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib56","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbr.2016.01.033","article-title":"Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors","volume":"303","author":"Sartim","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.euroneuro.2016.08.007_bib57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.beem.2008.09.001","article-title":"Use of cannabinoid CB1 receptor antagonists for the treatment of metabolic disorders","volume":"23","author":"Scheen","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib58","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total, protein-bound, and nonproteinsulfhydryl groups in tissue with Ellman\u05f3s reagent","volume":"25","author":"Sedlak","year":"1968","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib59","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s11606-007-0316-z","article-title":"Patients with Complex Chronic Diseases: perspectives on supporting self-management","volume":"3","author":"Sevick","year":"2007","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib60","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nprot.2012.044","article-title":"Using the rat forced swim test to assess antidepressant-like activity in rodents","volume":"7","author":"Slattery","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.psym.2012.08.002","article-title":"Exploring the association of psychological status with self-rated diabetes control: results from the Montreal evaluation of diabetes treatment study","volume":"54","author":"Smith","year":"2013","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1016\/j.euroneuro.2016.08.007_bib62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbr.2011.04.031","article-title":"Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice","volume":"223","author":"Umathe","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11011-010-9211-0","article-title":"Protein and lipid oxidative damage in streptozotocin-induced diabetic rats submitted to forced swimming test: the insulin and clonazepam effect","volume":"25","author":"Wayhs","year":"2010","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib64","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(01)00372-5","article-title":"Presynaptic specificity of endocannabinoid signaling in the hippocampus","volume":"31","author":"Wilson","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib65","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2337\/diacare.15.4.518","article-title":"Psychosocial state of patients with IDDM prone to recurrent episodes of severe hypoglycemia","volume":"15","author":"Wredling","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.euroneuro.2016.08.007_bib66","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.08.007_bib67","article-title":"Depression associated with diabetes: from pathophysiology to treatment","author":"Zanoveli","year":"2015","journal-title":"Curr. Diabetes Rev."},{"issue":"1","key":"10.1016\/j.euroneuro.2016.08.007_bib68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000442679","article-title":"Therapy with a selective cannabinoid receptor type 2 agonist limits albuminuria and renal injury in mice with type 2 diabetic nephropathy","volume":"132","author":"Zoja","year":"2016","journal-title":"Nephron"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1630164X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1630164X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T20:35:20Z","timestamp":1568406920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X1630164X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0924977X1630164X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.08.007","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}